Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (181-190 of 300) with videos related to

Pageof 30
Sort By:
Brain : a Journal of Neurology|November 21, 2023
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrumIgnacio Illán-Gala, Diego L Lorca-Puls, Boon Lead Tee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral ComplaintsMonica Rivera-Mindt, Micah J Savin, Vanessa Guzman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 9, 2012
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansionBaber K Khan, Jennifer S Yokoyama, Leonel T Takada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
Alzheimer Disease and Associated Disorders|March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer diseaseSuzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
NPJ Dementia|May 28, 2026
Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicityKiet Hua, Maryam R Pearson, Brandon I Apresa, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
JAMA Neurology|April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative DiseasesJun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Pageof 30

Showing results (181-190 of 300) with videos related to

Sort By:
Pageof 30
Brain : a Journal of Neurology|November 21, 2023
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrumIgnacio Illán-Gala, Diego L Lorca-Puls, Boon Lead Tee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral ComplaintsMonica Rivera-Mindt, Micah J Savin, Vanessa Guzman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 9, 2012
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansionBaber K Khan, Jennifer S Yokoyama, Leonel T Takada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
Alzheimer Disease and Associated Disorders|March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer diseaseSuzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
NPJ Dementia|May 28, 2026
Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicityKiet Hua, Maryam R Pearson, Brandon I Apresa, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
JAMA Neurology|April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative DiseasesJun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Pageof 30